Cytek Biosciences stock gains 2.25 percent near its yearly range

Published on 09/22/2026 at 10:52 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Cytek Biosciences stock traded at USD 4.72 on September 21, 2026, up 2.25 percent. Market capitalization stood at USD 600.51 million at the latest close.

CTKB, US23284C1053, Illustration mit AI erstellt.

Cytek Biosciences stock (ISIN US23284C1053) traded at USD 4.72 on the Nasdaq on September 21, 2026, up 2.25 percent from the prior close. The move gives the company a current market value of USD 600.51 million, while volume reached 649,719 shares at the latest close.

Trading data set the near term

MarketBeat reported the USD 4.72 quote and 2.25 percent daily gain during September 21, 2026 trading. Its latest-close data also show a USD 4.62 reference price, USD 600.51 million market capitalization and volume of 649,719 shares, so the quoted intraday and latest-close values must be read as separate market states rather than combined into one closing price.

For investors, the comparison between USD 4.72 and the latest-close value of USD 4.62 represents a USD 0.10 difference, equivalent to 2.16 percent relative to USD 4.62. The market reaction was therefore measurable, but the available trading data do not establish a company-specific reason for the move.

Financial figures remain period specific

Cytek Biosciences develops technology for high-parameter flow cytometry, but the available dated market material does not provide a sufficiently periodized revenue, earnings, margin or guidance figure for the current article. The actionable data point is therefore the quantified market comparison from September 21, 2026, supported by the Nasdaq listing and the reported trading statistics.

The scale of the company remains visible through its USD 600.51 million market capitalization and 649,719-share volume at the latest close. Those figures provide a clearer trading frame than an undated fundamental claim, because both are tied to a specific market state.

Cytek Biosciences stock closes at USD 4.62

Cytek Biosciences stock was listed on Nasdaq, with the latest close reported at USD 4.62 and a market capitalization of USD 600.51 million as of September 21, 2026. The intraday quote of USD 4.72 and daily gain of 2.25 percent were reported for the same trading date.